Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-003677-25Phase 4Terminated
Phase 4, open-label trial of levothyroxine in hypothyroidism (2 arms), sponsored by IBSA Group. Primary endpoint: Primary: absorption pattern based on circulating total T4. Started Dec 2012; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-003677-25.